Solid Biosciences Says FDA Grants Fast Track Designation to Duchenne Muscular Dystrophy Gene Therapy; Shares Rise

-- Solid Biosciences said Thursday that the US Food and Drug Administration has granted fast track designation to SGT-003, the company's Duchenne muscular dystrophy gene therapy candidate.
The...

Related Keywords

, Solid Biosciences Inc , Solid Biosciences , Markets ,